These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38825477)

  • 1. Effect of Perioperative Docetaxel-induced Limb Edema on Health-related Quality of Life in Patients with Early-stage Breast Cancer: A Prospective Observational Study.
    Matsumoto K; Morimoto Y; Wakatsuki J; Sakuma D; Mukouyama K; Inoue M; Kimura A; Hirosawa I; Watanabe K
    Yakugaku Zasshi; 2024; 144(6):685-690. PubMed ID: 38825477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.
    Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Kuroi K; Ohsumi S; Makino H; Katsumata N; Kuranami M; Suemasu K; Watanabe T; Hausheer FH
    Support Care Cancer; 2012 Dec; 20(12):3355-64. PubMed ID: 22584733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of the effect of docetaxel-induced edema on quality of life in patients with breast cancer and related factors: a prospective cohort study.
    Izawa T; Kobayashi A; Kawashima M; Kawaguchi-Sakita N; Nakakura A; Kataoka Y; Shide K; Mori Y; Yamazaki K; Toi M; Arao H
    BMC Womens Health; 2024 Mar; 24(1):165. PubMed ID: 38454375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative Safety Study of Original and Generic Docetaxel without Alcohol in the Treatment of Breast Cancer].
    Hara M; Eto T; Ijichi H; Nakamura Y; Koga C; Tajiri W; Okamoto M; Tokunaga E; Misumi N
    Gan To Kagaku Ryoho; 2022 Dec; 49(12):1355-1359. PubMed ID: 36539249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of oral dexamethasone given 24 hours previously on docetaxel-induced edema: a retrospective study].
    Kato A; Masuda N; Makihara K; Ueno H; Hirohata K; Yamauchi K; Yasojima H; Mizutani M; Yamamura J; Komori K
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):211-4. PubMed ID: 24743199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02.
    Ohsumi S; Shimozuma K; Ohashi Y; Takeuchi A; Suemasu K; Kuranami M; Ohno S; Watanabe T
    Oncology; 2012; 82(3):131-8. PubMed ID: 22433221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
    Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
    Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial.
    D'Almeida Preto D; Baston MT; Geraige CC; Augusto SB; de Oliveira MA; Mamere AE; Pinto GDJ; Dias JM; De Marchi PRM; Paiva BSR; Paiva CE
    BMC Cancer; 2019 Apr; 19(1):382. PubMed ID: 31023257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer.
    Brandberg Y; Johansson H; Hellström M; Gnant M; Möbus V; Greil R; Foukakis T; Bergh J;
    Breast Cancer Res Treat; 2020 May; 181(1):87-96. PubMed ID: 32232698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema.
    Lim HK; Kim KM; Jeong SY; Choi EK; Jung J
    Integr Cancer Ther; 2017 Dec; 16(4):496-504. PubMed ID: 27151585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QOL Evaluation of Nab-Paclitaxel and Docetaxel for Early Breast Cancer.
    Okuyama H; Nakamura S; Akashi-Tanaka S; Sawada T; Kuwayama T; Handa S; Kato Y
    Eur J Breast Health; 2018 Oct; 14(4):194-198. PubMed ID: 30288492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
    Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
    J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax).
    Al-Batran SE; Hozaeel W; Tauchert FK; Hofheinz RD; Hinke A; Windemuth-Kieselbach C; Hübner A; Burmester M; Koenigsmann M; Wiegand J; Zur Hausen G; Linsse B; Kuhl R; Pauligk C
    Ann Oncol; 2015 Jun; 26(6):1244-1248. PubMed ID: 25755108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer.
    Boyle FM; Smith IE; O'Shaughnessy J; Ejlertsen B; Buzdar AU; Fumoleau P; Gradishar W; Martin M; Moy B; Piccart-Gebhart M; Pritchard KI; Lindquist D; Amonkar M; Huang Y; Rappold E; Williams LS; Wang-Silvanto J; Kaneko T; Finkelstein DM; Goss PE;
    Eur J Cancer; 2015 Apr; 51(6):685-96. PubMed ID: 25752740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
    Twelves C; Cortés J; O'Shaughnessy J; Awada A; Perez EA; Im SA; Gómez-Pardo P; Schwartzberg LS; Diéras V; Yardley DA; Potter DA; Mailliez A; Moreno-Aspitia A; Ahn JS; Zhao C; Hoch U; Tagliaferri M; Hannah AL; Rugo HS
    Eur J Cancer; 2017 May; 76():205-215. PubMed ID: 28360015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper extremity function and quality of life in patients with breast cancer related lymphedema.
    Bojinović-Rodić D; Popović-Petrović S; Tomić S; Markez S; Živanić D
    Vojnosanit Pregl; 2016 Sep; 73(9):825-30. PubMed ID: 29320146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.
    Zaheed M; Wilcken N; Willson ML; O'Connell DL; Goodwin A
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012873. PubMed ID: 30776132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors Contributing to the Occurrence of Edema in Breast Cancer Patients Receiving DTX Treatment].
    Uno K; Takada S; Hashishita H; Endo M
    Gan To Kagaku Ryoho; 2020 Jul; 47(7):1069-1073. PubMed ID: 32668854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
    Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
    Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation study of epirubicin and docetaxel in patients with advanced or recurrent breast cancer.
    Ichinose I; Hamada Y; Mitsuyama S; Ishikawa E; Ikeda T; Kobayashi S; Horikoshi N; Tamura K
    Chemotherapy; 2008; 54(5):379-85. PubMed ID: 18758179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.